Professor Shinji Fukuda Featured in Financial Times 2020 List of Asia-Pacific High-Growth Companies
(from April 2020)
Transborder Medical Research Center (TMRC) member Professor Shinji Fukuda of Keio University and CEO of Megabologenomic Inc., has been featured in a Financial Times article recognising his company’s research and success, while ranking 50th on the FT list of “Asia-Pacific High-Growth Companies 2020”.
This ranking is based on a survey targeting companies whose headquarters are located in the Asia-Pacific region and lists the top 500 companies with consideration to the compound annual growth rate of their revenues across 2015 to 2018.
The company is built upon research in the field of Metabologenomics in collaboration with TMRC. The Metabologenomic Inc technology and service is now providing important positive economic and community health benefits within the Asia-Pacific region.
The full article is available on the Financial Times website.